share_log

Jefferies Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $529

Futu News ·  Oct 21 20:31  · Ratings

Jefferies analyst David Windley maintains $Elevance Health (ELV.US)$ with a buy rating, and adjusts the target price from $600 to $529.

According to TipRanks data, the analyst has a success rate of 62.6% and a total average return of 11.5% over the past year.

AnalystRecentRatingAutoNews_82334523291606_20241021_7d01ded18b7b9799879344ce873eb76773eff938_1729585894529720_nn_en

Furthermore, according to the comprehensive report, the opinions of $Elevance Health (ELV.US)$'s main analysts recently are as follows:

  • Medicaid pressures are overshadowing the positive developments within the commercial and Carelon divisions of Elevance Health, following the company's third-quarter report.

  • Elevance Health experienced a setback with its Q3 earnings not meeting expectations and subsequent guidance reduction. The shares saw a decrease following management's revised 2024 EPS outlook, as the challenges within Medicaid were more significant than previously forecasted. Despite these short-term obstacles, the long-term perspective on the company remains stable, with the anticipation that the current Medicaid mix challenges will be temporary.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment